跳至主要内容
临床试验/NCT03200041
NCT03200041已完成不适用

Clinical Evaluation of the IONA Test for Non-invasive Pre Natal Screening in Twin Pregnancies

Premaitha Health2 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2016年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
1,000
试验地点
2
主要终点
Number of IONA test results which are concordant or discordant with Invasive test or Birth outcome.

研究概览

简要总结

The purpose of this study is to evaluate the performance of the IONA® test which is a non-invasive prenatal test (NIPT) for Down's syndrome and other chromosomal abnormalities in twin pregnancies, from a maternal blood sample.

详细描述

350 low risk and 150 high risk women with twin pregnancies will be recruited to produce a large cohort evaluation the use of the IONA test in twin pregnancies for Downs, Edwards and Patau syndrome. Reserve samples will also be used to further develop the test for other chromosomal abnormalities.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Screening
盲法
None

入排标准

年龄范围
16 Years 至 —(Child, Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Currently pregnant with twin foetuses at time of entry to study
  • Have had or are about to have a conventional screening test (combined/quad test, ultrasound scan or other NIPT)
  • If identified as high risk, intend to undergo prenatal invasive diagnosis and/or undergoing invasive prenatal therapy such as laser treatment for TTTS where a sample of amniotic fluid is taken for karyotyping.

排除标准

  • Participant herself has down syndrome or other chromosomal abnormality

结局指标

主要结局

Number of IONA test results which are concordant or discordant with Invasive test or Birth outcome.

时间窗: 18 months

IONA test results will be compared to Karyotyping from birth outcome and invasive procedures.

次要结局

未报告次要终点

研究者

发起方
Premaitha Health
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验